H
Hellmut Samonigg
Researcher at Medical University of Graz
Publications - 178
Citations - 12156
Hellmut Samonigg is an academic researcher from Medical University of Graz. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 51, co-authored 178 publications receiving 11412 citations. Previous affiliations of Hellmut Samonigg include University of Graz & Vienna General Hospital.
Papers
More filters
Journal ArticleDOI
Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
Michael Gnant,Brigitte Mlineritsch,Walter Schippinger,G. Luschin-Ebengreuth,Sabine Pöstlberger,Christian Menzel,Raimund Jakesz,Michael Seifert,Michael Hubalek,Vesna Bjelic-Radisic,Hellmut Samonigg,C. Tausch,Holger Eidtmann,Guenther G. Steger,Werner Kwasny,Peter Dubsky,M. Fridrik,Florian Fitzal,Michael Stierer,Ernst Rücklinger,Richard Greil +20 more
TL;DR: The addition of zoledronic acid to adjuvant endocrine therapy improves disease-free survival in premenopausal patients with estrogen-responsive early breast cancer.
Journal ArticleDOI
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
Raimund Jakesz,Walter Jonat,Michael Gnant,Martina Mittlboeck,Richard Greil,Christoph Tausch,Joern Hilfrich,Werner Kwasny,Christian Menzel,Hellmut Samonigg,Michael Seifert,Guenther Gademann,Manfred Kaufmann +12 more
TL;DR: A combined analysis of data from two prospective, multicentre, randomised, open-label trials lends support to a switch from tamoxifen to anastrozole in patients who have completed 2 years' adjuvant tamoxIFen.
Journal ArticleDOI
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy.
M. D. Green,H. Koelbl,José Baselga,A. Galid,V. Guillem,Pere Gascón,Salvatore Siena,Roy I. Lalisang,Hellmut Samonigg,M. R. Clemens,V. Zani,B. C. Liang,J. Renwick,Martine Piccart +13 more
TL;DR: A single fixed dose of pegfilgrastim administered once per cycle of chemotherapy was comparable to multiple daily injections of fil grastim in safely providing neutrophil support during myelosuppressive chemotherapy.
Journal ArticleDOI
Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing
Ellen Heitzer,Martina Auer,Christin Gasch,Martin Pichler,Peter Ulz,Eva M. Hoffmann,Sigurd Lax,Julie Waldispuehl-Geigl,Oliver Mauermann,Carolin Lackner,Gerald Höfler,Florian Eisner,Heinz Sill,Hellmut Samonigg,Klaus Pantel,Sabine Riethdorf,Thomas Bauernhofer,Jochen B. Geigl,Michael R. Speicher +18 more
TL;DR: This study paves the way to use CTCs as a liquid biopsy in patients with cancer, providing more effective options to monitor tumor genomes that are prone to change during progression, treatment, and relapse.
Journal ArticleDOI
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Michael Stotz,Armin Gerger,Florian Eisner,Joanna Szkandera,Hans Loibner,Anna Lena Ress,Peter Kornprat,Wael Al-Zoughbi,F S Seggewies,C. Lackner,Tatjana Stojakovic,Hellmut Samonigg,Gerald Hoefler,Martin Pichler +13 more
TL;DR: Risk prediction for cancer-related end points using NLR does add independent prognostic information to other well-established prognostic factors in patients with PC, regardless of the undergoing therapeutic modality.